查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1978208

全球血小板濃縮血漿和幹細胞脫髮症治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 137 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計富血小板血漿 (PRP) 和幹細胞脫髮症治療的市場規模將從 2025 年的 4.9736 億美元成長到 2034 年的 8.094 億美元，2026 年至 2034 年的複合年成長率為 5.56%。

受脫髮症盛行率上升和人們美容意識增強的推動，富血小板血漿（PRP）和幹細胞脫髮症治療的全球市場正經歷強勁成長。 PRP和幹細胞療法等非手術再生醫學因其微創性和良好的治療效果而日益受到歡迎。美容手術需求的不斷成長也顯著促進了市場成長。

關鍵成長要素包括再生醫學技術的進步和專業診所的增加。可支配收入的成長和社群媒體的影響力正在推動對個人化脫髮治療方案的需求成長。幹細胞療法的持續研究正在提高治療效果和安全性，進一步增強了市場需求。

展望未來，隨著個人化再生醫學療法的日益普及，市場預計將持續成長。皮膚科醫師對該療法的接受度不斷提高，以及臨床證據的不斷積累，都將為這一成長提供支持。在新興市場，醫療旅遊和美容診所的擴張帶來了巨大的發展機會。總體而言，再生醫學領域的創新有望推動市場的長期發展。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球血小板濃縮血漿和幹細胞脫髮症治療市場：依治療方法

  • 市場分析、洞察與預測
  • 富血小板血漿療法
  • 幹細胞療法（骨髓來源、脂肪來源）

第5章 全球血小板濃縮血漿和幹細胞脫髮症治療市場：按適應症分類

  • 市場分析、洞察與預測
  • 雄性脫髮症
  • 先天性脫髮症
  • 瘢痕脫髮症
  • 其他

第6章 全球血小板濃縮血漿和幹細胞脫髮症治療市場：按最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 皮膚科診所
  • 其他

第7章 全球血小板濃縮血漿和幹細胞脫髮症治療市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Kerastem
    • Eclipse
    • Regen Lab SA
    • Restore Hair
    • RepliCel Life Sciences
    • Histogen Inc
    • Glofinn Oy
    • ACell Inc
    • HairClone Ltd
    • Follica Inc
簡介目錄
Product Code: VMR112114204

The Platelet Rich Plasma and Stem Cell Alopecia Treatment Market size is expected to reach USD 809.40 Million in 2034 from USD 497.36 Million (2025) growing at a CAGR of 5.56% during 2026-2034.

The Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market is witnessing strong growth due to increasing prevalence of hair loss conditions and rising aesthetic awareness. Non-surgical regenerative therapies such as PRP and stem cell treatments are gaining popularity for their minimally invasive nature and promising results. Growing demand for cosmetic procedures is significantly boosting market expansion.

Key growth drivers include technological advancements in regenerative medicine and increasing availability of specialized clinics. Rising disposable incomes and social media influence are encouraging individuals to seek hair restoration solutions. Continuous research in stem cell therapy is improving treatment efficacy and safety profiles, further strengthening market demand.

Looking ahead, the market is expected to expand with greater adoption of personalized regenerative treatments. Increasing acceptance among dermatologists and improved clinical evidence will support growth. Emerging markets present significant opportunities due to expanding medical tourism and aesthetic clinics. Overall, innovation in regenerative therapies will drive long-term market development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Treatment

  • Platelet Rich Plasma Therapy
  • Stem Cell Therapy (Bone Marrow, Adipose)

By Indication

  • Androgenic Alopecia
  • Congenital Alopecia
  • Cicatricial or Scarring Alopecia
  • Others

By End-user

  • Hospitals
  • Dermatology Clinics
  • Others

COMPANIES PROFILED

  • Kerastem, Eclipse, Regen Lab SA, Restore Hair, RepliCel Life Sciences, Histogen Inc, Glofinn Oy, ACell Inc, HairClone Ltd, Follica Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT MARKET: BY TREATMENT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Treatment
  • 4.2. Platelet Rich Plasma Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Stem Cell Therapy (Bone Marrow, Adipose) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT MARKET: BY INDICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Indication
  • 5.2. Androgenic Alopecia Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Congenital Alopecia Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Cicatricial or Scarring Alopecia Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Dermatology Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Treatment
    • 7.2.2 By Indication
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Treatment
    • 7.3.2 By Indication
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Treatment
    • 7.4.2 By Indication
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Treatment
    • 7.5.2 By Indication
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Treatment
    • 7.6.2 By Indication
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PLATELET RICH PLASMA AND STEM CELL ALOPECIA TREATMENT INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Kerastem
    • 9.2.2 Eclipse
    • 9.2.3 Regen Lab SA
    • 9.2.4 Restore Hair
    • 9.2.5 RepliCel Life Sciences
    • 9.2.6 Histogen Inc
    • 9.2.7 Glofinn Oy
    • 9.2.8 ACell Inc
    • 9.2.9 HairClone Ltd
    • 9.2.10 Follica Inc